Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Compugen to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference
-
Palladyne AI and FANUC America Announce Strategic Collaboration to Advance Intelligent Robotic Automation
-
VION Biosciences Expands Integrated Platform Across Biopharma Services and Diagnostic Workflow Capabilities
-
Definium Therapeutics Receives Breakthrough Therapy Designation for DT120 (lysergide) Orally Disintegrating Tablet (ODT) in Major Depressive Disorder (MDD) Following Positive Phase 3 Results
-
NetraMark Appoints Former Global Atlantic Investment Office President and Scotiabank U.S. CEO Kevin Felix as Strategic Advisor
-
LX Pantos Successfully Completes Complex Defense Logistics Project for Advanced Weapons
-
BETA Technologies to Participate in Upcoming Investor Conferences
-
CDAO Awards Red Cell Partners $100M Agreement to Pilot Shared Savings
-
BrewDog Roars into Rugby with Five-Year Leicester Tigers Partnership, Bringing Punk Energy to Welford Road
-
Erasca to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
-
OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference
-
Beamr and VAST Data Partner to AI-enhance and Monetize Video Archives with NVIDIA
-
Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026
-
NRx Pharmaceuticals to Participate in Upcoming Investor Conferences
-
DraftKings Extends Agreement with IC360 to Enhance Integrity Monitoring and Combat Athlete Harassment Across Sportsbook and Prediction Market Platforms
-
Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer
-
Adlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADC
-
Monte Rosa Therapeutics Announces Milestone Achievement Associated with Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)
-
LiveU, AP bring new connectivity, workflow tech to global newsgathering, deploying largest LU900Q fleet worldwide
-
Cloverleaf Bio Raises $33 Million Seed Financing to Advance Novel RNA-Based Cancer Therapeutics
-
Infex Therapeutics presents new Phase IIa data for RESP-X at ERS Congress 2026, providing further evidence on exploratory efficacy endpoints supporting progression to later stage development
-
CoinShares Co-Founder and Non-Executive Director Daniel Masters Adopts Pre-Scheduled Trading Plan
-
A New Force in the Surf Park Economy
-
Palantir and Nebius Partner to Deliver a Complete Sovereign AI Stack to Palantir Customers
-
Bristol Myers Squibb Announces Positive Topline Results from Registrational Phase 2 QUINTESSENTIAL Trial of the Potential First-in-Class GPRC5D-Directed CAR T Cell Therapy, Arlocabtagene Autoleucel ..
-
ABM Reports Fiscal Third Quarter 2026 Results
-
YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST
-
YieldMax® ETFs Announces Weekly Distributions for Group 1 ETFs
-
A Winning Partnership for Veterans: Glocoms Inc. and Dr. Maurence Anguh Selected for VA Driver Rehabilitation Services
-
Treno Scope Launches Liquidity Analysis Module, with Initial Focus on the Indonesian Market
-
Pharvaris Announces Positive Topline Data from CHAPTER-3 Pivotal Study of Deucrictibant XR for Prophylaxis of HAE Attacks
-
The Contractor Who Takes One Job at a Time Just Made His Name Untouchable
-
QuikStor Arrives at SSA with its Most Powerful Platform Yet. Built by Operators, For Operators.
-
New clinical evidence presented at PAINWeek 2026 demonstrates the powerful, long-lasting relief of TYLENOL® with Naproxen in post-surgical pain studies
-
American Healthcare REIT Names Jon Crosier Chief Technology Officer
-
Solaris Energy Infrastructure Raises 2026 and Initiates First Quarter 2027 Guidance
-
Merck to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
-
Jacobs to support regulatory and consenting strategy for UK’s MESH Energy Storage Project
-
Protalix BioTherapeutics to Participate in Upcoming September 2026 Investor Conferences
-
American Savings Bank Announces Launch of Initial Public Offering
-
The More Than $1.1 Trillion US Consumer Goods Market Is Splitting in Two, According to NIQ and World Data Lab Analysis
-
Bullish releases August 2026 monthly metrics
-
2026 CIFTIS Culture and Tourism Services Section Media Briefing Held in Beijing
-
Ivanhoe Mines Increases the Size of Massive Western Forelands' Copper Discovery by 30%
-
Max S. Yudovich, M.D., Joins Central Ohio Urology Group, an Affiliate of U.S. Urology Partners
-
MemeToro $MT Launch Prediction; Diving into MemeToro Presale Tokenomics, Memecoin Ecosystem and AI Agent
-
Acer Reports Revenues for August at NT$30.18 Billion and Year-to-August at NT$214.81 Billion; Both Marking 13-Year Highs for the Same Period
-
NIQ Expands Product Intelligence Across Western Europe, Strengthening the Foundation for AI-Driven Commerce
-
HEALWELL's DARWEN(TM) to Power AI-Driven Clinical Trial Matching for WELLTRUST(TM), a Network of Over 100,000 Consented Patients
-
WELL Health Announces WELLTRUST(TM) Surpasses 100,000 Patient Consents
